Our data showing an inhibitory effect of estrogen in tumor formation in male nude mice suggest that estrogen or estrogenic compounds have therapeutic potential in patients with W4P-LHB-induced HCC. This evidence concerns the gene LHB and hepatocellular carcinoma.